Related Experiment Videos
Glucocorticoids attenuate T cell receptor signaling
F Van Laethem1, E Baus, L A Smyth
1Laboratoire de Physiologie Animale, Institut de Biologie et de Médecine Moléculaires, Université Libre de Bruxelles, 6041 Gosselies, Belgium.
The Journal of Experimental Medicine
|April 3, 2001
Summary
Glucocorticoids (GCs) inhibit T cell activation by disrupting early signaling events after T cell receptor (TCR) ligation. This impacts immune responses by affecting T cell development and peripheral function.
Area of Science:
- Immunology
- Endocrinology
- Cellular Signaling
Background:
- Glucocorticoids (GCs) are known to inhibit peripheral T cell immune responses.
- Endogenous GCs may also regulate T cell development within the thymus.
- T cell activation relies on signals from T cell receptor (TCR) complexes.
Purpose of the Study:
- To investigate the effects of GCs on T cell signaling pathways.
- To determine if GCs impact early signaling events following TCR engagement.
Main Methods:
- Stimulation of T cells using anti-CD3 monoclonal antibodies and agonist peptides.
- Analysis of tyrosine phosphorylation of TCR-associated signaling molecules.
- Assessment of membrane compartmentalization of src protein tyrosine kinases.
Main Results:
- Dexamethasone, a synthetic GC, inhibited early signaling events upon TCR ligation.
- Key substrates like the zeta chain and ZAP70 kinase showed reduced tyrosine phosphorylation.
- Hypophosphorylation correlated with altered membrane compartmentalization, not reduced kinase activity.
Conclusions:
- GCs inhibit T cell activation by interfering with early phosphorylation events after TCR ligation.
- This mechanism complements the known effects of GCs on gene transcription in peripheral immune responses.
- GCs play a dual role in regulating T cell immunity, affecting both development and activation.